Antileukemic Activity of Sulforaphane in Primary Blasts from Patients Affected by Myelo- and Lympho-Proliferative Disorders and in Hypoxic Conditions

por Fimognari, Carmela, Turrini, Eleonora, Sestili, Piero, Calcabrini, Cinzia, Carulli, Giovanni, Fontanelli, Giulia, Rousseau, Martina, Cantelli-Forti, Giorgio, Hrelia, Patrizia
Publicado 2014

Real-Life Experience with Pomalidomide plus Low-Dose Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma: A Retrospective and Prospective Study

por Del Giudice, Maria Livia, Gozzetti, Alessandro, Antonioli, Elisabetta, Orciuolo, Enrico, Ghio, Francesco, Ciofini, Sara, Candi, Veronica, Fontanelli, Giulia, Attucci, Irene, Formica, Giuseppe, Bocchia, Monica, Galimberti, Sara, Petrini, Mario, Buda, Gabriele
Publicado 2021

Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patients

por Bocchia, Monica, Galimberti, Sara, Aprile, Lara, Sicuranza, Anna, Gozzini, Antonella, Santilli, Francesca, Abruzzese, Elisabetta, Baratè, Claudia, Scappini, Barbara, Fontanelli, Giulia, Trawinska, Monika Malgorzata, Defina, Marzia, Gozzetti, Alessandro, Bosi, Alberto, Petrini, Mario, Puccetti, Luca
Publicado 2016

The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia

por Galimberti, Sara, Bucelli, Cristina, Arrigoni, Elena, Baratè, Claudia, Grassi, Susanna, Ricci, Federica, Guerrini, Francesca, Ciabatti, Elena, Fava, Carmen, D’Avolio, Antonio, Fontanelli, Giulia, Cambrin, Giovanna Rege, Isidori, Alessandro, Loscocco, Federica, Caocci, Giovanni, Greco, Marianna, Bocchia, Monica, Aprile, Lara, Gozzini, Antonella, Scappini, Barbara, Cattaneo, Daniele, Scortechini, Anna Rita, La Nasa, Giorgio, Bosi, Alberto, Leoni, Pietro, Danesi, Romano, Saglio, Giuseppe, Visani, Giuseppe, Cortelezzi, Agostino, Petrini, Mario, Iurlo, Alessandra, Di Paolo, Antonello
Publicado 2017